Somatostatin receptor imaging in small cell lung cancer
- 1 July 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (8) , 1429-1431
- https://doi.org/10.1016/0959-8049(96)00078-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndromeEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- The value of octreotide scintigraphy in patients with lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.Journal of Clinical Oncology, 1993
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- 3. Imaging and therapy control of tumours by receptor scintigraphy with 111In-octreotideNuclear Medicine Communications, 1993
- Scintigraphic imaging of lung tumours with a radiolabelled somatostatin analogueNuclear Medicine Communications, 1993
- Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancerBritish Journal of Cancer, 1991
- Staging and prognostic factors in small cell lung cancer: a consensus reportLung Cancer, 1989